D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
IART holding history
Integra Lifesciences Holdings Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IART overviewAll 13F holders of IARTFull Q2 2026 holdings
- Shares (Q2 2026)
- 507,252
- Value
- $9.11M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 507,252 | $9.11M | <0.1% | +117,753+30.2% | Added | Holders |
| Q1 2026 | 389,499 | $3.67M | <0.1% | −80,098−17.1% | Reduced | Holders |
| Q4 2025 | 469,597 | $5.83M | <0.1% | −155,554−24.9% | Reduced | Holders |
| Q3 2025 | 625,151 | $8.96M | <0.1% | −43,153−6.5% | Reduced | Holders |
| Q2 2025 | 668,304 | $8.20M | <0.1% | +326,674+95.6% | Added | Holders |
| Q1 2025 | 341,630 | $7.51M | <0.1% | −391,921−53.4% | Reduced | Holders |
| Q4 2024 | 733,551 | $16.6M | <0.1% | −289,713−28.3% | Reduced | Holders |
| Q3 2024 | 1,023,264 | $18.6M | <0.1% | +167,912+19.6% | Added | Holders |
| Q2 2024 | 855,352 | $24.9M | <0.1% | +335,557+64.6% | Added | Holders |
| Q1 2024 | 519,795 | $18.4M | <0.1% | +107,938+26.2% | Added | Holders |
| Q4 2023 | 411,857 | $17.9M | <0.1% | −35,733−8.0% | Reduced | Holders |
| Q3 2023 | 447,590 | $17.1M | <0.1% | +43,922+10.9% | Added | Holders |
| Q2 2023 | 403,668 | $16.6M | <0.1% | +54,618+15.6% | Added | Holders |
| Q1 2023 | 349,050 | $20.0M | <0.1% | −14,743−4.1% | Reduced | Holders |
| Q4 2022 | 363,793 | $20.4M | <0.1% | +56,439+18.4% | Added | Holders |
| Q3 2022 | 307,354 | $13.0M | <0.1% | +3,048+1.0% | Added | Holders |
| Q2 2022 | 304,306 | $16.4M | <0.1% | +42,826+16.4% | Added | Holders |
| Q1 2022 | 261,480 | $16.8M | <0.1% | +227,936+679.5% | Added | Holders |
| Q4 2021 | 33,544 | $2.25M | <0.1% | −12,500−27.1% | Reduced | Holders |
| Q3 2021 | 46,044 | $3.15M | <0.1% | −44,190−49.0% | Reduced | Holders |
| Q2 2021 | 90,234 | $6.16M | <0.1% | −47,145−34.3% | Reduced | Holders |
| Q1 2021 | 137,379 | $9.49M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.